By contrast, in individuals with TP53 gene mutations with a higher penetrance for all types of cancer in classic LFS carriers, the lifetime cancer risk was estimated at over 70% in men and nearly 100% in women, possibly due to BC cases [33,34,35,36,37]. Here, TP53 is linked to breast cancer.